// App-Quantinova.ai

4584 : Apoptosis-mediated AXL activation: Contribution to metastatic cancers

Researchers

Presenter

  • Annelien Zweemer

Principal Investigators

  • Aaron Meyer

  • Douglas Lauffenburger

Medical Centers

  • FMI, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • AXL receptor tyrosine kinase

  • Hepatocyte growth factor receptor

Drug/Treatment

  • Phosphatidylserine

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A